Search hospitals > California > Los Angeles

University of Southern California

Claim this profile
Los Angeles, California 90033
Global Leader in Cancer
Global Leader in Alzheimer's Disease
Conducts research for Stroke
Conducts research for Heart Failure
Conducts research for Parotid Gland Cancer
660 reported clinical trials
61 medical researchers
Photo of University of Southern California in Los AngelesPhoto of University of Southern California in Los Angeles

Summary

University of Southern California is a medical facility located in Los Angeles, California. This center is recognized for care of Cancer, Alzheimer's Disease, Stroke, Heart Failure, Parotid Gland Cancer and other specialties. University of Southern California is involved with conducting 660 clinical trials across 841 conditions. There are 61 research doctors associated with this hospital, such as Anthony El-Khoueiry, MD, Heinz-Josef Lenz, Jacob Thomas, MD, and Jorge J. Nieva.

Area of expertise

1Cancer
Global Leader
University of Southern California has run 39 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
HER2 positive
2Alzheimer's Disease
Global Leader
University of Southern California has run 32 trials for Alzheimer's Disease. Some of their research focus areas include:
APOE4 positive

Top PIs

Clinical Trials running at University of Southern California

Breast Cancer
Colorectal Cancer
Cancer
Lung Cancer
Liver Cancer
Squamous Cell Carcinoma
Bladder Cancer
Solid Tumors
Lymphoma
Endometrial Cancer
Image of trial facility.

NX-1607

for Advanced Cancer

This trial is testing NX-1607, a new experimental drug, in adults with advanced cancers that don't respond to standard treatments. The goal is to see if NX-1607 can safely stop or reduce cancer growth, either by itself or with another drug called paclitaxel. Paclitaxel is a widely used anti-cancer drug for treating various types of solid malignant tumors including breast, ovarian, and lung cancers.
Recruiting1 award Phase 1
Image of trial facility.

VLS-1488

for Advanced Cancer

This trial tests VLS-1488, a new drug for advanced cancers, to find the safest and most effective dose. It targets patients needing new treatment options and checks how the drug interacts with other medications and food.
Recruiting1 award Phase 1 & 26 criteria
Image of trial facility.

QXL138AM

for Multiple Myeloma

Study QXL138AM-001 is a Phase 1a/1b study to investigate the safety, pharmacokinetics, and preliminary activity of QXL138AM in subjects with locally advanced un-resectable and/or metastatic solid tumors and multiple myeloma. The study is an open-label, multicenter, first in human study to be conducted in two major parts which are further organized into two sub-parts. Part A Dose Escalation is a modified 3+3 with the first two cohorts consisting of one subject each based on the low clinical starting dose. Dose escalation in solid tumors (Part A1) will be followed by dose finding in multiple myeloma (Part A2). Part B consists of dose expansion in solid tumors (Part B1) and multiple myeloma (Part B2) using the recommended dose for expansion from Part A
Recruiting1 award Phase 12 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at University of Southern California?
Where is University of Southern California located?
Who should I call to ask about financial aid or insurance network?
What insurance does University of Southern California accept?
What awards or recognition has University of Southern California received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security